Bhinneka News Online: Reuters Health Report: April 3, 2017

Monday, 3 April 2017

Reuters Health Report: April 3, 2017

Click to View in Browser

Monday, April 3, 2017

Babies cry more in UK, Canada and Italy, less in Germany, study finds

LONDON (Reuters) - Babies cry more in Britain, Canada, Italy and Netherlands than in other countries, while newborns in Denmark, Germany and Japan cry and fuss the least, researchers said on Monday.

Trump talks healthcare with Republican critic on golf course

STERLING, Va. (Reuters) - President Donald Trump golfed with a vocal Republican critic of his healthcare push on Sunday, as he insisted efforts to repeal and replace President Barack Obama's signature healthcare law were not dead.

China reports six new bird flu cases, one death

BEIJING (Reuters) - China reported six new cases of H7N9 bird flu including one death in Hunan after live poultry markets in the province were shuttered last month.

Mylan says EpiPen manufacturing partner to expand device recall

(Reuters) - Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.

U.S. Zika vaccine begins second phase of testing

CHICAGO (Reuters) - Researchers have begun the second phase of testing of a Zika vaccine developed by U.S. government scientists in a trial that could yield preliminary results as early as the end of 2017.

U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) - A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics Inc related to its multiple sclerosis drug Ampyra, causing the stock to tumble 24 percent before trading was halted.

Myanmar trains midwives to tackle maternal death rate

YANGON (Reuters) - Myanmar is training up hundreds of midwives in an effort to reduce the number of women who die in childbirth, one of many social policy reforms launched by the country as it emerges from decades of military rule.

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

(Reuters) - A U.S. patent board on Friday ruled against Danish drugmaker Forward Pharma A/S, finding Biogen's patents on its blockbuster multiple sclerosis drug Tecfidera to be valid.

Philip Morris asks for FDA nod to sell heated tobacco device

LONDON (Reuters) - Philip Morris International said on Friday it has applied for pre-market approval of its iQOS heated tobacco product with the U.S. Food and Drug Administration.

Pharmacy chain works to help curb opioid epidemic

(Reuters Health) - The drugstore chain Walgreens is taking a three-pronged approach to combat the public health crisis stemming from prescription opioids, according to a team of pharmacists and other clinicians from the company.